NeuroSense Therapeutics

NRSN • NASDAQ • Stock Fundamentals

NeuroSense Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alon Ben-Noon, with a market cap of $24.8M.

Market Cap$24.8M

Employees16.0

CEOAlon Ben-Noon

CountryIsrael

Healthcare

Biotechnology

Most Recent EarningsApr 6, 2026 · 2 months 11 days agoQ4 2025

Next EarningsJun 22, 2026 · In 5 daysBefore Market Open · Q1 2026

Financials

Based on Q4 2025 filing

Common questions about NeuroSense Therapeutics

NeuroSense Therapeutics (NRSN) has a market capitalization of $24.8M and trades on NASDAQ.

NeuroSense Therapeutics has approximately 16 employees.